BB BIOTECH AG - 31 Dec 2024 SCHEDULE 13G/A Report for Esperion Therapeutics, Inc. Common Stock (ESPR)

Filing Manager: BB BIOTECH AG
Reporting Manager: BB Biotech AG
Security: Esperion Therapeutics, Inc. Common Stock
Symbol: ESPR
Shares outstanding: 199M shares
Disclosed Ownership: 9.94M shares
Ownership: 5%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 14:37:40 UTC
Date of event: 31 Dec 2024
Next filing: 10 Mar 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BB Biotech AG	5%	9.94M	0	9.94M	/s/ Martin Gubler	Martin Gubler/Signatory Authority
Biotech Target N.V.	5%	9.94M	0	9.94M	/s/ Jan Bootsma	Jan Bootsma/Signatory Authority